NYSE:STE (UK) Also trade in: Germany

Steris PLC

$ 146.25 -1.62 (-1.1%)
Volume: 473,035 Avg Vol (1m): 573,424
Market Cap $: 12.36 Bil Enterprise Value $: 13.39 Bil
P/E (TTM): 46.33 P/B: 3.90
Earnings Power Value 16.36
Net Current Asset Value -10.42
Tangible Book 1.88
Projected FCF 52.64
Median P/S Value 58.12
Graham Number 11.56
Peter Lynch Value 23.15
DCF (FCF Based) 46.54
DCF (Earnings Based) 33.71
1Y (-%)

Financial Strength : 6.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.18
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 0.32, Max: 10000
Current: 0.18
0.04
10000
Equity-to-Asset 0.62
Equity-to-Asset range over the past 10 years
Min: 0.34, Med: 0.58, Max: 0.89
Current: 0.62
0.34
0.89
Debt-to-Equity 0.40
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.34, Max: 0.76
Current: 0.4
0
0.76
Debt-to-EBITDA 2.06
Debt-to-EBITDA range over the past 10 years
Min: 0.73, Med: 1.66, Max: 4.38
Current: 2.06
0.73
4.38
Interest Coverage 8.61
Interest Coverage range over the past 10 years
Min: 4.97, Med: 11.77, Max: 18.48
Current: 8.61
4.97
18.48
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.28
DISTRESS
GREY
SAFE
Beneish M-Score -2.58
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 7.82%
WACC 5.27%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 15.13
Operating Margin range over the past 10 years
Min: 7.16, Med: 13.67, Max: 16.58
Current: 15.13
7.16
16.58
Net Margin % 9.85
Net Margin range over the past 10 years
Min: 4.21, Med: 8.25, Max: 11.1
Current: 9.85
4.21
11.1
ROE % 8.61
ROE range over the past 10 years
Min: 3.78, Med: 12.93, Max: 18.11
Current: 8.61
3.78
18.11
ROA % 5.29
ROA range over the past 10 years
Min: 2.14, Med: 6.94, Max: 10.46
Current: 5.29
2.14
10.46
ROC (Joel Greenblatt) % 27.87
ROC (Joel Greenblatt) range over the past 10 years
Min: 16.35, Med: 30.4, Max: 38.9
Current: 27.87
16.35
38.9
3-Year Total Revenue Growth Rate 12.30
3-Year Revenue Growth Rate range over the past 10 years
Min: -30.9, Med: 7.8, Max: 189
Current: -0.3
-30.9
189
3-Year Total EBITDA Growth Rate 22.30
3-Year EBITDA Growth Rate range over the past 10 years
Min: -26, Med: 7.5, Max: 522
Current: 8.6
-26
522
3-Year EPS w/o NRI Growth Rate 14.60
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 0.3, Max: 293.6
Current: 14.6
0
293.6

» STE's 30-Y Financials

Financials (Next Earnings Date: 2019-08-08)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:STE

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Equipment    NAICS : 339113    SIC : 3842
Compare NYSE:VAR NAS:HOLX NAS:XRAY XSWX:STMN XSWX:SOONE TSE:7733 NYSE:TFX NYSE:WST XTER:AFX NYSE:COO NAS:MASI NYSE:RMD OCSE:DEMANT NYSE:HRC TSE:7747 NYSE:HAE NAS:NVCR NZSE:FPH OSTO:EKTA B OSTO:LIFCO B
Traded in other countries 2TG.Germany
Address Rutherford House, Stephensons Way Chaddesden, Derby, GBR, DE21 6LY
STERIS PLC operates in four segments: healthcare products, healthcare specialty services, life sciences, and applied sterilization technologies. The healthcare products segment generates the majority of revenue and offers infection prevention equipment and consumables for healthcare providers. The healthcare specialty services segment provides services such as hospital sterilization, instrument repairs, and linen management. The life sciences segment provides equipment, consumables, and maintenance services to pharmaceutical manufacturers and research facilities. The applied sterilization technologies segment provides sterilization and laboratory services to medical device and pharmaceutical manufacturers. Steris generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 46.33
PE Ratio range over the past 10 years
Min: 11.08, Med: 28.69, Max: 60.81
Current: 46.33
11.08
60.81
Forward PE Ratio 26.95
N/A
PE Ratio without NRI 46.33
PE without NRI range over the past 10 years
Min: 11.08, Med: 28.69, Max: 60.81
Current: 46.33
11.08
60.81
Price-to-Owner-Earnings 36.13
Price-to-Owner-Earnings range over the past 10 years
Min: 8.67, Med: 21.34, Max: 60.59
Current: 36.13
8.67
60.59
PB Ratio 3.90
PB Ratio range over the past 10 years
Min: 1.68, Med: 2.51, Max: 4.19
Current: 3.9
1.68
4.19
PS Ratio 4.46
PS Ratio range over the past 10 years
Min: 0.94, Med: 1.82, Max: 4.76
Current: 4.46
0.94
4.76
Price-to-Free-Cash-Flow 38.40
Price-to-Free-Cash-Flow range over the past 10 years
Min: 8.74, Med: 25.29, Max: 113.68
Current: 38.4
8.74
113.68
Price-to-Operating-Cash-Flow 25.47
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 7.09, Med: 14.45, Max: 26.7
Current: 25.47
7.09
26.7
EV-to-EBIT 34.64
EV-to-EBIT range over the past 10 years
Min: 7.1, Med: 18.9, Max: 40.3
Current: 34.64
7.1
40.3
EV-to-EBITDA 22.16
EV-to-EBITDA range over the past 10 years
Min: 5.4, Med: 12.9, Max: 24.9
Current: 22.16
5.4
24.9
EV-to-Revenue 4.80
EV-to-Revenue range over the past 10 years
Min: 1, Med: 2, Max: 5
Current: 4.8
1
5
PEG Ratio 12.78
PEG Ratio range over the past 10 years
Min: 1.36, Med: 2.68, Max: 231.65
Current: 12.78
1.36
231.65
Shiller PE Ratio 64.22
Shiller PE Ratio range over the past 10 years
Min: 17.91, Med: 28.26, Max: 67.29
Current: 64.22
17.91
67.29
Current Ratio 2.56
Current Ratio range over the past 10 years
Min: 1.44, Med: 2.5, Max: 8.51
Current: 2.56
1.44
8.51
Quick Ratio 1.99
Quick Ratio range over the past 10 years
Min: 0.92, Med: 1.9, Max: 7.97
Current: 1.99
0.92
7.97
Days Inventory 51.14
Days Inventory range over the past 10 years
Min: 44.92, Med: 59.42, Max: 70.76
Current: 51.14
44.92
70.76
Days Sales Outstanding 68.17
Days Sales Outstanding range over the past 10 years
Min: 62.38, Med: 69.06, Max: 82.3
Current: 68.17
62.38
82.3
Days Payable 31.28
Days Payable range over the past 10 years
Min: 30.7, Med: 33.62, Max: 43.62
Current: 31.28
30.7
43.62

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 0.92
Trailing Dividend Yield range over the past 10 years
Min: 0.68, Med: 1.42, Max: 2.34
Current: 0.92
0.68
2.34
Dividend Payout Ratio 0.41
Dividend Payout Ratio range over the past 10 years
Min: 0.16, Med: 0.37, Max: 0.85
Current: 0.41
0.16
0.85
3-Year Dividend Growth Rate (Per Share) 10.40
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 34.7
Current: 10.4
0
34.7
Forward Dividend Yield % 0.92
N/A
Yield-on-Cost (5-Year) % 1.50
Yield-on-Cost (5y) range over the past 10 years
Min: 1.11, Med: 2.31, Max: 3.8
Current: 1.5
1.11
3.8
3-Year Share Buyback Rate -12.40
3-Year Share Buyback Rate range over the past 10 years
Min: -37.6, Med: -0.6, Max: 5.2
Current: -12.4
-37.6
5.2

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 77.79
Price-to-Tangible-Book range over the past 10 years
Min: 2.69, Med: 4.88, Max: 1749.4
Current: 77.79
2.69
1749.4
Price-to-Projected-FCF 2.78
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.81, Med: 1.66, Max: 58.73
Current: 2.78
0.81
58.73
Price-to-DCF (Earnings Based) 4.34
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.44, Med: 1.69, Max: 3.9
Current: 4.34
0.44
3.9
Price-to-Median-PS-Value 2.52
Price-to-Median-PS-Value range over the past 10 years
Min: 0.35, Med: 0.9, Max: 3.34
Current: 2.52
0.35
3.34
Price-to-Peter-Lynch-Fair-Value 6.32
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.83, Med: 2.08, Max: 41.83
Current: 6.32
0.83
41.83
Price-to-Graham-Number 12.65
Price-to-Graham-Number range over the past 10 years
Min: 1.19, Med: 2.59, Max: 48.87
Current: 12.65
1.19
48.87
Earnings Yield (Joel Greenblatt) % 2.89
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.5, Med: 5.3, Max: 14
Current: 2.89
2.5
14
Forward Rate of Return (Yacktman) % 9.28
Forward Rate of Return range over the past 10 years
Min: -1.7, Med: 9.9, Max: 18.4
Current: 9.28
-1.7
18.4

More Statistics

Revenue (TTM) (Mil) $ 2,729.93
EPS (TTM) $ 3.15
Beta 0.77
Volatility % 21.71
52-Week Range $ 99.14 - 154.09
Shares Outstanding (Mil) 84.51

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y